1. Home
  2. RNXT vs ZCMD Comparison

RNXT vs ZCMD Comparison

Compare RNXT & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • ZCMD
  • Stock Information
  • Founded
  • RNXT 2012
  • ZCMD 2012
  • Country
  • RNXT United States
  • ZCMD China
  • Employees
  • RNXT N/A
  • ZCMD N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • ZCMD Other Consumer Services
  • Sector
  • RNXT Health Care
  • ZCMD Real Estate
  • Exchange
  • RNXT Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • RNXT 44.6M
  • ZCMD 29.0M
  • IPO Year
  • RNXT 2021
  • ZCMD 2020
  • Fundamental
  • Price
  • RNXT $1.30
  • ZCMD $1.18
  • Analyst Decision
  • RNXT Strong Buy
  • ZCMD
  • Analyst Count
  • RNXT 2
  • ZCMD 0
  • Target Price
  • RNXT $7.25
  • ZCMD N/A
  • AVG Volume (30 Days)
  • RNXT 141.1K
  • ZCMD 650.7K
  • Earning Date
  • RNXT 08-12-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • RNXT N/A
  • ZCMD N/A
  • EPS Growth
  • RNXT N/A
  • ZCMD N/A
  • EPS
  • RNXT N/A
  • ZCMD N/A
  • Revenue
  • RNXT $240,000.00
  • ZCMD $15,864,773.00
  • Revenue This Year
  • RNXT $3,186.05
  • ZCMD N/A
  • Revenue Next Year
  • RNXT $291.93
  • ZCMD N/A
  • P/E Ratio
  • RNXT N/A
  • ZCMD N/A
  • Revenue Growth
  • RNXT N/A
  • ZCMD N/A
  • 52 Week Low
  • RNXT $0.75
  • ZCMD $0.95
  • 52 Week High
  • RNXT $1.69
  • ZCMD $2.97
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 48.98
  • ZCMD 49.32
  • Support Level
  • RNXT $1.27
  • ZCMD $1.12
  • Resistance Level
  • RNXT $1.38
  • ZCMD $1.24
  • Average True Range (ATR)
  • RNXT 0.06
  • ZCMD 0.13
  • MACD
  • RNXT -0.01
  • ZCMD -0.00
  • Stochastic Oscillator
  • RNXT 23.23
  • ZCMD 26.71

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

Share on Social Networks: